Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anat Reiner

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JBMR Plus|September 29, 2025
Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutationChen Abramovitch-Dahan, Svetlana Katchkovsky, Yuval Zur, et al.
Journal of Immunological Methods|December 19, 2015
SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®)Chaim Putterman, Alan Wu, Anat Reiner-Benaim, et al.
Journal of Pain and Symptom Management|May 18, 2026
Developing a preliminarily validated competency-based integrative oncology training questionnaireEran Ben-Arye, Orit Gressel, Elad Schiff, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Cancer Discovery|September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsIthai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
Bone|March 10, 2023
Vertebrae but not femur marrow fat transiently decreases in response to body weight loss in an 18-month randomized control trialNoa Ofir, Yuval Mizrakli, Yariv Greenshpan, et al.
Clinical Kidney Journal|April 13, 2019
G1 is the major <i>APOL1</i> risk allele for hypertension-attributed nephropathy in Central AfricaErnest K Sumaili, Revital Shemer, Etty Kruzel-Davila, et al.
Frontiers in Medicine|September 13, 2021
HIV Viremia Is Associated With <i>APOL1</i> Variants and Reduced JC-ViruriaEtty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JBMR Plus|September 29, 2025
Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutationChen Abramovitch-Dahan, Svetlana Katchkovsky, Yuval Zur, et al.
Journal of Immunological Methods|December 19, 2015
SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®)Chaim Putterman, Alan Wu, Anat Reiner-Benaim, et al.
Journal of Pain and Symptom Management|May 18, 2026
Developing a preliminarily validated competency-based integrative oncology training questionnaireEran Ben-Arye, Orit Gressel, Elad Schiff, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Cancer Discovery|September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsIthai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
Bone|March 10, 2023
Vertebrae but not femur marrow fat transiently decreases in response to body weight loss in an 18-month randomized control trialNoa Ofir, Yuval Mizrakli, Yariv Greenshpan, et al.
Clinical Kidney Journal|April 13, 2019
G1 is the major <i>APOL1</i> risk allele for hypertension-attributed nephropathy in Central AfricaErnest K Sumaili, Revital Shemer, Etty Kruzel-Davila, et al.
Frontiers in Medicine|September 13, 2021
HIV Viremia Is Associated With <i>APOL1</i> Variants and Reduced JC-ViruriaEtty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
Pageof 5